Shopping Cart
- Remove All
- Your shopping cart is currently empty
GPX4-IN-4 (Compound 24) is a potent inhibitor of GPX4, employed in cancer research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,670 | 8-10 weeks | |
50 mg | $2,180 | 8-10 weeks | |
100 mg | $2,800 | 8-10 weeks |
Description | GPX4-IN-4 (Compound 24) is a potent inhibitor of GPX4, employed in cancer research [1]. |
In vitro | GPX4-IN-4 (Compound 24) reduces HT1080 cell viability in a dose- and time-dependent fashion at concentrations ranging from 0 to 1000 nM and durations up to 24 hours [1]. Similarly, GPX4-IN-4 demonstrates inhibitory effects on NCI-H1703 cell viability over 72 hours, with EC50 values of 0.117 μM without Fer-1 and 4.74 μM with Fer-1 [1]. |
In vivo | GPX4-IN-4 (Compound 24; 100 and 200 mg/kg; i.p.; once) targets renal GPX4 and induces the expression of PD biomarkers in mice [1]. Despite partial target engagement observed in tumor masses, GPX4-IN-4 (50 mg/kg; i.p.; daily for 20 days) does not affect the growth of WSU-DLCL2 tumors in mice [1]. |
Molecular Weight | 460.93 |
Formula | C22H21ClN2O5S |
Cas No. | 2920221-53-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.